Analysis | Metabolite Name | Measured Value | Units | CASE_CONTROL | Chemotherapy | Drug | Race | TIMEPOINT | Tamoxyfen | Taxane |
---|---|---|---|---|---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 443169 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 451606 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 468380 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 480563 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 495554 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 502753 | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 532374 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 532572 | Peak area | Control | N | Letrozole | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 535551 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 546187 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 554799 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 559847 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 566896 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 572623 | Peak area | Control | N | Letrozole | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 577300 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 588512 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 601624 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 622184 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 624493 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 625165 | Peak area | Control | Y | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 627494 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 627937 | Peak area | Case | N | Letrozole | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 636428 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 639611 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 663526 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 666684 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 672907 | Peak area | Case | N | Letrozole | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 672951 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 675696 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 676465 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 688371 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 695710 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 721224 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 724144 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 730894 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 748759 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 774825 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 778217 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 778707 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 780894 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 781631 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 795853 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 801190 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 807612 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 812184 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 812725 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 816638 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 830842 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 831078 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 835808 | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 838898 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 840437 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 856225 | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 862330 | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 867906 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 870925 | Peak area | Control | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 876625 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 883945 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 891590 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 892917 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 911534 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 916336 | Peak area | Case | N | Exemestane | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 918338 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 925026 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 942415 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 945765 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 958067 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 959291 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 964502 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 966447 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 972801 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 984506 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 991233 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 991711 | Peak area | Control | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 998300 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 1003738 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 1004097 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 1006902 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 1027735 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 1052791 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 1052834 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 1060138 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 1062881 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 1089967 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 1095537 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 1097015 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 1110431 | Peak area | Control | N | Exemestane | Black | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 1114161 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 1153777 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 1163181 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 1168910 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 1184113 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 1211084 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 1241776 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 1248494 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 1323716 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 1333723 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 1377503 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 1408088 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | METHIONINE (CAS# 63-68-3); (M+H)+ | 1492822 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |